-
Will EU give ground on 2035 combustion-engine ban?
-
England nemesis Starc stretches Australia lead in Gabba Ashes Test
-
Banana skin 'double whammy' derails McIlroy at Australian Open
-
Epic Greaves double ton earns West Indies draw in first NZ Test
-
Thunder roll to 14th straight NBA win, Celtics beat depleted Lakers
-
Myanmar citizens head to early polls in Bangkok
-
Starvation fears as more heavy rain threaten flood-ruined Indonesia
-
Sri Lanka unveils cyclone aid plan as rains persist
-
Avatar 3 aims to become end-of-year blockbuster
-
Contenders plot path to 2026 World Cup glory after Trump steals show at draw
-
Greaves leads dramatic West Indies run chase in NZ Test nail-biter
-
World record-holders Walsh, Smith grab wins at US Open
-
Ukraine, US to meet for third day, agree 'real progress' depends on Russia
-
Double wicket strike as New Zealand eye victory over West Indies
-
Peace medal and YMCA: Trump steals the show at World Cup draw
-
NBA legend Jordan in court as NASCAR anti-trust case begins
-
How coaches reacted to 2026 World Cup draw
-
Glasgow down Sale as Stomers win at Bayonne in Champions Cup
-
Trump takes aim at Europe in new security strategy
-
Witness in South Africa justice-system crimes probe shot dead
-
Tuchel urges England not to get carried away plotting route to World Cup glory
-
Russian ambassador slams EU frozen assets plan for Ukraine
-
2026 World Cup draw is kind to favorites as Trump takes limelight
-
WHO chief upbeat on missing piece of pandemic treaty
-
US vaccine panel upends hepatitis B advice in latest Trump-era shift
-
Ancelotti says Brazil have 'difficult' World Cup group with Morocco
-
Kriecmayr wins weather-disrupted Beaver Creek super-G
-
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
-
Mixed day for global stocks as market digest huge Netflix deal
-
England boss Tuchel wary of 'surprise' in World Cup draw
-
10 university students die in Peru restaurant fire
-
'Sinners' tops Critics Choice nominations
-
Netflix's Warner Bros. acquisition sparks backlash
-
Frank Gehry: five key works
-
US Supreme Court to weigh Trump bid to end birthright citizenship
-
Frank Gehry, master architect with a flair for drama, dead at 96
-
'It doesn't make sense': Trump wants to rename American football
-
A day after peace accord signed, shelling forces DRC locals to flee
-
Draw for 2026 World Cup kind to favorites as Trump takes center stage
-
Netflix to buy Warner Bros. in deal of the decade
-
US sanctions equate us with drug traffickers: ICC dep. prosecutor
-
Migration and crime fears loom over Chile's presidential runoff
-
French officer charged after police fracture woman's skull
-
Fresh data show US consumers still strained by inflation
-
Eurovision reels from boycotts over Israel
-
Trump takes centre stage as 2026 World Cup draw takes place
-
Trump all smiles as he wins FIFA's new peace prize
-
US panel votes to end recommending all newborns receive hepatitis B vaccine
-
Title favourite Norris reflects on 'positive' Abu Dhabi practice
-
Stocks consolidate as US inflation worries undermine Fed rate hopes
| SCS | -0.56% | 16.14 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| RBGPF | 0% | 78.35 | $ | |
| BP | -3.91% | 35.83 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| BCE | 1.4% | 23.55 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| VOD | -1.31% | 12.47 | $ |
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator
Biotech startups often encounter administrative roadblocks on their path to achieving breakthroughs in life sciences. Today, ZAGENO, the leading AI-powered marketplace for lab supplies, and Hatch.Bio Labs, a premier biotech incubator, join forces to eliminate these challenges.
ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
This strategic partnership empowers Hatch.Bio residents with a streamlined lab supply procurement process, allowing them to prioritize groundbreaking research. ZAGENO's platform offers an Amazon-like shopping experience for lab supplies, featuring:
Effortless Management: Discounted rates, easy price comparison of 5,300+ suppliers, single bill-to options, and automated order tracking.
Dedicated Support: Fast onboarding, procurement best practices, and frequent on-site guidance to maximize platform value.
Reduced Costs: Exclusive discounts for Hatch members, with free access for smaller startups.
"Biotech startups are at the forefront of innovation, but administrative hurdles can delay their progress," says Florian Wegener, CEO and Founder of ZAGENO. "Our partnership with Hatch.Bio simplifies lab supply ordering for their members, saving them valuable time and resources."
James Weis, Hatch.Bio CEO, adds, "This collaboration provides our residents with a critical operational advantage, allowing them to streamline operations and accelerate research."
Through this partnership, Hatch.Bio tenants will gain seamless access to ZAGENO's AI-powered lab supply marketplace. By integrating ZAGENO's platform with Hatch.Bio's facilities and support, this collaboration simplifies procurement, automates tracking, and minimizes administrative tasks, freeing researchers to focus on advancing their research to the clinic.
About ZAGENO
ZAGENO is transforming lab supply procurement with the industry's largest AI-powered marketplace, featuring over 40 million products from 5,300+ global suppliers. Scientists, lab managers, and procurement teams rely on ZAGENO's all-in-one platform for painless lab supply procurement that optimizes budgets and enhances productivity. With automated order and delivery tracking, custom workflows, real-time spend analytics, and offloaded supplier management, ZAGENO empowers labs of all sizes to achieve full lab supply ordering automation. Explore ZAGENO's marketplace and discover how it can streamline your lab supply procurement: www.zageno.com or request access at bit.ly/HatchBio-Labs.
About Hatch.Bio Labs
Hatch.Bio Labs is the premier biotechnology and life sciences incubation platform dedicated to reducing operational barriers for biotechnology and life sciences companies. We provide best-in-class, highly flexible, and cost-effective laboratory and office facilities, natively integrated with comprehensive scientific and operational support and strategic partnerships within a modern technology stack-all to help our resident companies grow more rapidly and efficiently. Our mission is to empower biotech pioneers to develop transformative technologies and advance the pace of biotechnology innovation. For more information and to inquire about becoming a tenant, visit www.hatch.bio.
Contact Information
Stephanie Harold
[email protected]
+1 (857) 477-8479
SOURCE: ZAGENO
X.Matos--PC